154719-20-7

Basic information

• Product Name: 1,5-dideoxy-2,3,6-Tri-O-benzyl-1,5-{[5-(trimethylsilyl)pentyl]imino}-D-glucitol
• CAS NO: 154719-20-7
• Molecular Weight: 575.864
• Mol File: 154719-20-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1,5-dideoxy-2,3,6-Tri-O-benzyl-1,5-{[5-(trimethylsilyl)pentyl]imino}-D-glucitol(CAS DataBase Reference)
• NIST Chemistry Reference: 1,5-dideoxy-2,3,6-Tri-O-benzyl-1,5-{[5-(trimethylsilyl)pentyl]imino}-D-glucitol(154719-20-7)
• EPA Substance Registry System: 1,5-dideoxy-2,3,6-Tri-O-benzyl-1,5-{[5-(trimethylsilyl)pentyl]imino}-D-glucitol(154719-20-7)

Safety Data

• Hazardous Substances Data: 154719-20-7(Hazardous Substances Data)

Upstream product

• 154673-52-6 5-trimethylsilyl-pentanol, methanesulfonate 
• 17898-25-8 (5-hexenyl)trimethylsilane 
• 18246-65-6 5-hydroxypentyl-trimethyl-silan 
• 2344-83-4 (3-chloropropyl)trimethylsilane 
• 154673-51-5 5-Iodopentyltrimethylsilane 
• 127214-75-9 2,3,6-tri-O-benzyl-1,5-dideoxy-1,5-imino-D-glucitol 

Relevant articles and documents

New deoxynojirimycin derivatives as potent inhibitors of intestinal α-glucohydrolases

New N-alkyl, alkenyl and benzyl substituted DNJ derivatives incorporating a silicon atom in the substituent were synthesised. Kinetic parameters (K(i), t( 1/4 )) for inhibition of rat intestinal α-glucohydrolases as well as human lysosomal α-glucosidases

N-derivatives of 1-deoxy nojirimycin

This invention relates to novel N-derivatives of 1-deoxy nojirimycin, to the method for their preparation and to their use in the treatment of diabetes and the use against retro-viruses, particularly in the treatment of acquired immuno-deficiency syndrome